The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Merck Sharp & Dome
Stock and Other Ownership Interests - Merck Sharp & Dome
 
Consulting or Advisory Role - Amgen; Bayer; Lilly; Nektar; Omeros; Puretech; Seagen; Tempus
Research Funding - EMD Serono; Epizyme; Immune Design; Janssen; Karyopharm Therapeutics; Lilly; Merck; OncoSec; Presage Biosciences
A phase I/II study of pembrolizumab (Pem) and doxorubicin (Dox) in treating patients with metastatic/unresectable sarcoma.
 
Seth Pollack
No Relationships to Disclose
 
Mary Weber Redman
Consulting or Advisory Role - Ignyta; Ignyta
 
Michael Wagner
Consulting or Advisory Role - Tempus
Research Funding - Merck (Inst)
 
Elizabeth Trice Loggers
Research Funding - Bayer (Inst); Daiichi Sankyo (Inst); Epizyme (Inst)
 
Kelsey K. Baker
No Relationships to Disclose
 
Sabrina McDonnell
No Relationships to Disclose
 
Jeffrey Gregory
No Relationships to Disclose
 
Vanessa C. Copeland
No Relationships to Disclose
 
Kathryn J. Hammer
No Relationships to Disclose
 
Rylee Johnson
No Relationships to Disclose
 
Roxanne Moore
Travel, Accommodations, Expenses - Deciphera; SpringWorks Therapeutics
 
Michael Shahnazari
No Relationships to Disclose
 
Steven Matthew Townson
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Clinigen Group; Daiichi Sankyo; Deciphera; Eisai; Epizyme; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; PharmaMar; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Lee D. Cranmer
Consulting or Advisory Role - Blueprint Medicines
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Lilly (Inst)